Article
HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer
4 May 2024
Abstract excerpt
Gastric cancer remains among the deadliest neoplasms worldwide, with limited therapeutic options. Since efficacies of targeted therapies are unsatisfactory, drugs with broader mechanisms of action rather than a single oncogene inhibition are needed. Preclinical studies have identified histone deacetylases (HDAC) as potential therapeutic targets in gastric cancer. However, the mechanism(s) of action of HDAC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
